<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03004924</url>
  </required_header>
  <id_info>
    <org_study_id>SHP640-303</org_study_id>
    <secondary_id>2016-003361-25</secondary_id>
    <nct_id>NCT03004924</nct_id>
  </id_info>
  <brief_title>Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo</brief_title>
  <official_title>A Phase 3, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of SHP640 (PVP-Iodine 0.6% and Dexamethasone 0.1%) Ophthalmic Suspension Compared to Placebo in the Treatment of Bacterial Conjunctivitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shire</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shire</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if an investigational treatment is effective
      compared with placebo and PVP-Iodine in the treatment of adults and children with bacterial
      conjunctivitis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 29, 2017</start_date>
  <completion_date type="Anticipated">March 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Resolution status between SHP640 and placebo as Measured by absence of Bulbar Conjunctival Injection and ocular conjunctival discharge</measure>
    <time_frame>Day 5</time_frame>
    <description>Clinical resolution of bacterial conjunctivitis is defined as the absence (score=0) of bulbar conjunctival injection and ocular conjunctival discharge in the study eye. The study eye is defined based on subject's bulbar conjunctival redness and ocular conjunctival discharge scores at baseline as well as his/her bacterial culture results at baseline. Bulbar conjunctival injection will be assessed based on a 0-4 scale which uses pictures from the validated bulbar redness (VBR) scale. Watery conjunctival discharge will be assessed based on a 0-3 scale.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bacterial Eradication Status between SHP640 and Placebo as Measured by Absence of All Bacterial Species Present at or Above Pathological Threshold at Baseline</measure>
    <time_frame>Day 5</time_frame>
    <description>Bacterial eradication status of the study eye is defined as absence of all bacterial species present at or above pathological threshold at baseline in the study eye at Day 5. The study eye is defined based on subject's bulbar conjunctival redness and ocular conjunctival discharge scores at baseline as well as his/her bacterial culture results at baseline.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">721</enrollment>
  <condition>Bacterial Conjunctivitis</condition>
  <arm_group>
    <arm_group_label>SHP640</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Instill 1 drop of SHP640 (0.6 percent (%) povidone-iodine [PVP-I] and 0.1% Dexamethasone and) ophthalmic suspension in each eye 4 times daily (QID) for 7 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PVP-I 0.6%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Instill 1 drop of 0.6% PVP-I ophthalmic solution in each eye 4 times QID for 7 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Instill 1 drop of placebo ophthalmic solution in each eye 4 times QID for 7 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SHP640</intervention_name>
    <description>Instill 1 drop of SHP640 (0.6% povidone-iodine [PVPI] and 0.1% Dexamethasone ) ophthalmic suspension in each eye QID (with a minimum of 2 hours between doses) for 7 days.</description>
    <arm_group_label>SHP640</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PVP-I 0.6%</intervention_name>
    <description>Instill 1 drop of 0.6% PVP-I ophthalmic solution in each eye 4 times QID (with a minimum of 2 hours between doses) for 7 days.</description>
    <arm_group_label>PVP-I 0.6%</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Instill 1 drop of placebo ophthalmic solution in each eye 4 times QID (with a minimum of 2 hours between doses) for 7 days.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  An understanding, ability, and willingness to fully comply with study procedures and
             restrictions (by the parent(s), guardian, or legally authorized representative, if
             applicable).

          -  Ability to voluntarily provide written, signed, and dated (personally or via a
             parent(s), guardian, or legally authorized representative(s) informed consent (and
             assent, if applicable) to participate in the study.

          -  Subjects of any age at Visit 1 (Note: subjects less than (&lt;) 3 months of age at Visit
             1 must have been full-term, that is (ie,) greater than or equal to (&gt;=) 37 weeks
             gestational age at birth).

          -  Have a negative AdenoPlusÂ® test in both eyes within 24 hours of Visit 1 or at Visit 1.

          -  Have a clinical diagnosis of suspected bacterial conjunctivitis in at least 1 eye
             confirmed by the presence of the following minimal clinical signs and symptoms in that
             same eye:

               1. Report presence of signs and/or symptoms of bacterial conjunctivitis for less
                  than or equal to (&lt;=) 4 days prior to Visit 1

               2. Bulbar conjunctival injection: a grade of &gt;= 1 on 0-4 scale of Bulbar
                  Conjunctival Injection Scale

               3. Ocular conjunctival discharge: a grade of &gt;= 1 (mild) on a 0-3 scale of Ocular
                  Conjunctival Discharge Scale

          -  Be willing to discontinue contact lens wear for the duration of the study.

          -  Have a Best Corrected Visual Acuity (BCVA) of 0.60 logMAR or better in each eye as
             measured using an Early Treatment Diabetic Retinopathy Study (ETDRS) chart. BCVA will
             be assessed by an age appropriate method in accordance with the AAP Policy Statement
             for Visual System Assessment in Infants, Children, and Young Adults by Pediatricians
             (Donahue and Baker, 2016; American Academy of Pediatrics, 2016). The policy statement
             recommends formal vision screening can begin at 3 years of age. VA measurements for
             children under the age of 3 will be done at the discretion of the investigator. If not
             done, child should be able to fixate on and follow a moving object, except subjects &lt;
             2 months of age who have not yet developed this ability. Subjects &lt; 2 months will be
             enrolled at the discretion of investigator.

          -  Male, or non-pregnant, non-lactating female who agrees to comply with any applicable
             contraceptive requirements of the protocol or females of non-childbearing potential.

        Exclusion Criteria:

          -  Current or recurrent disease that could affect the action, absorption, or disposition
             of the investigational product, or clinical or laboratory assessments, per
             investigator's discretion.

          -  Current or relevant history of physical or psychiatric illness, any medical disorder
             that may make the subject unlikely to fully complete the study, or any condition that
             presents undue risk from the investigational product or procedures.

          -  Have known or suspected intolerance or hypersensitivity to the investigational
             product, closely related compounds, or any of the stated ingredients.

          -  Prior enrollment in a FST-100 or SHP640 clinical study.

          -  Subjects who are employees, or immediate family members of employees (who are directly
             related to study conduct), at the investigational site.

          -  Have a history of ocular surgical intervention within &lt;= 6 months prior to Visit 1 or
             planned for the period of the study.

          -  Have a preplanned overnight hospitalization during the period of the study.

          -  Have presence of any intraocular, corneal, or conjunctival ocular inflammation
             (example [eg,] uveitis, iritis, ulcerative keratitis, chronic blepharoconjunctivitis),
             other than bacterial conjunctivitis.

          -  Have active or a history of ocular herpes.

          -  Have at enrollment or within &lt;= 30 days of Visit 1, a clinical presentation more
             consistent with the diagnosis of non-infectious conjunctivitis (except presumed
             seasonal/perennial allergic conjunctivitis) or non-bacterial ocular infection (eg,
             viral, fungal, acanthamoebal, or other parasitic). Note: history or concomitant
             presence of presumed seasonal or perennial allergic conjunctivitis signs/symptoms is
             not exclusionary.

          -  Neonates or infants (ie, subjects less than 12 months of age) who have suspected or
             confirmed (based on the result of any test conducted prior to screening)
             conjunctivitis of gonococcal, chlamydial, herpetic or chemical origin.

          -  Neonates or infants (ie, subjects less than 12 months of age) whose birth mothers had
             any sexually transmitted disease within 1 month of delivery or any history of genital
             herpes.

          -  Presence of nasolacrimal duct obstruction at Visit 1 (Day 1).

          -  Presence of any significant ophthalmic condition (eg, Retinopathy of Prematurity,
             congenital cataract, congenital glaucoma) or other congenital disorder with ophthalmic
             involvement that could affect study variables.

          -  Be a known intraocular pressure (IOP) steroid responder, have a known history or
             current diagnosis of glaucoma or be a glaucoma suspect.

          -  Have any known clinically significant optic nerve defects.

          -  Have a history of recurrent corneal erosion syndrome, either idiopathic or secondary
             to previous corneal trauma or dry eye syndrome; presence of corneal epithelial defect
             or any significant corneal opacity at Visit 1.

          -  Presence of significant, active condition in the posterior segment that requires
             invasive treatment (eg, intravitreal treatment with vascular endothelial growth factor
             inhibitors or corticosteroids) and may progress during the study participation period.

          -  Have used any topical ocular or systemic antibiotics within &lt;= 7 days of enrollment.

          -  Have used any topical ocular non-steroidal anti-inflammatory drugs within &lt;= 1 day of
             enrollment.

          -  Have used any topical ophthalmic steroids in the last &lt;= 14 days.

          -  Have used any systemic corticosteroid agents within &lt;= 14 days of Day 1. Stable
             (initiated &gt;= 30 days prior to enrollment) use of inhaled and nasal corticosteroids is
             allowed, given no anticipated change in dose for the duration of the study. Topical
             dermal steroids are allowed except in the periocular area.

          -  Have used non-corticosteroid immunosuppressive agents within &lt;= 14 days of Day 1.

          -  Have used any topical ophthalmic products, including tear substitutes, and
             over-the-counter preparations such as lid scrubs, within 2 hours of Visit 1 and be
             unable to discontinue all topical ophthalmic products for the duration of the study.
             Use of hot or cold compresses is also not permitted during the study.

          -  Have any significant ocular disease (eg, Sjogren's syndrome) or any uncontrolled
             systemic disease or debilitating disease (eg, cardiovascular disease, hypertension,
             sexually transmitted diseases/infections, diabetes, or cystic fibrosis) that may
             affect the study parameters, per investigator's discretion.

          -  Any known history of immunodeficiency disorder or known active conditions predisposing
             to immunodeficiency, such as human immunodeficiency virus, hepatitis B or C, evidence
             of active hepatitis A (anti-hepatitis A virus immunoglobulin M), or organ or bone
             marrow transplantation.

          -  Within 30 days prior to the first dose of investigational product:

               1. Have used an investigational product or device, or

               2. Have been enrolled in a clinical study (including vaccine studies) that, in the
                  investigator's opinion, may impact this Shire-sponsored study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shire Physician</last_name>
    <role>Study Director</role>
    <affiliation>Shire</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shire Contact</last_name>
    <phone>+1 866 842 5335</phone>
    <email>ClinicalTransparency@Shire.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Arizona Eye Center</name>
      <address>
        <city>Chandler</city>
        <state>Arizona</state>
        <zip>85225</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jerry Tolle Jr</last_name>
      <phone>480-999-5458</phone>
      <email>jerry.tolle@doctrials.com</email>
    </contact>
    <investigator>
      <last_name>Michael Depenbusch</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cornea and Cataract Consultants of Arizona</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Komer</last_name>
      <phone>602-258-4342</phone>
      <email>ccazresearch@aol.com</email>
    </contact>
    <investigator>
      <last_name>Jung Dao</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>M&amp;M Eye Institute</name>
      <address>
        <city>Prescott</city>
        <state>Arizona</state>
        <zip>86301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sean Cook</last_name>
      <phone>480-999-5458</phone>
      <email>sean.cook@doctrials.com</email>
    </contact>
    <investigator>
      <last_name>Steven Mortenson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Schwartz Laser Eye Center</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katie O'Brien</last_name>
      <phone>480-483-3937</phone>
      <email>katieo@schwartzlaser.com</email>
    </contact>
    <investigator>
      <last_name>Marc Bloomstein</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Walman Eye Center</name>
      <address>
        <city>Sun City</city>
        <state>Arizona</state>
        <zip>85351</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sean Moriarty</last_name>
      <phone>480-999-5458</phone>
      <email>sean.moriarty@doctrials.com</email>
    </contact>
    <investigator>
      <last_name>Gerald Walman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eye Care Center</name>
      <address>
        <city>Concord</city>
        <state>California</state>
        <zip>94520</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuanuan Wang</last_name>
      <phone>925-686-2020</phone>
      <email>Yyw0219@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Clark Tsai</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mark B. Kislinger, MD, Inc.</name>
      <address>
        <city>Glendora</city>
        <state>California</state>
        <zip>91741</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shelby Wade</last_name>
      <phone>626-335-0535</phone>
      <email>shelby.foothilleye@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Vicky Pai</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inland Eye Specialists</name>
      <address>
        <city>Hemet</city>
        <state>California</state>
        <zip>92545</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norlisha Borntrager</last_name>
      <phone>951-492-4205</phone>
      <email>Norlishab@inlandeyespecialists.com</email>
    </contact>
    <investigator>
      <last_name>Robert Sorenson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lakeside Vision Center</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92604</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zarah Chhoet</last_name>
      <phone>949-733-2002</phone>
      <email>Studycoordinator@drduzmanmd.com</email>
    </contact>
    <investigator>
      <last_name>Eran Duzman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hull Eye Center</name>
      <address>
        <city>Lancaster</city>
        <state>California</state>
        <zip>93534</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kaci Taylor</last_name>
      <phone>661-945-4502</phone>
      <phone_ext>237</phone_ext>
      <email>ktaylor@hecresearch.com</email>
    </contact>
    <investigator>
      <last_name>Janet Kim</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eye Physicians of Long Beach</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90808</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marisela Silva</last_name>
      <phone>562-421-2757</phone>
      <email>marisela@eplb.com</email>
    </contact>
    <investigator>
      <last_name>Wayne Freeman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sok H. Nam, M.D. Inc.</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90020</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Kim</last_name>
      <phone>213-368-0388</phone>
      <email>rebecca@nameyecenter.com</email>
    </contact>
    <investigator>
      <last_name>Sok Nam</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Macy Eye Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott Kaesemeyer</last_name>
      <phone>310-657-2777</phone>
      <email>scott@macyeyecenter.com</email>
    </contact>
    <investigator>
      <last_name>Jonathan Macy</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shasta Eye Medical Group, Inc.</name>
      <address>
        <city>Redding</city>
        <state>California</state>
        <zip>96001</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Miller</last_name>
      <phone>530-223-2500</phone>
      <phone_ext>2104</phone_ext>
      <email>studycoordinator@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Bruce Silverstein</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sacramento Eye Consultants</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95815</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaime Phillips</last_name>
      <phone>916-649-1515</phone>
      <phone_ext>223</phone_ext>
      <email>jaimep@saceye.com</email>
    </contact>
    <investigator>
      <last_name>Samuel Lee</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>WCCT Global</name>
      <address>
        <city>Santa Ana</city>
        <state>California</state>
        <zip>92705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Hong</last_name>
      <phone>714-380-2329</phone>
      <email>ann.hong@wcct.com</email>
    </contact>
    <investigator>
      <last_name>Michael Sheety</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wolstan &amp; Goldberg Eye Associates</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90505</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brittney Rodriguez</last_name>
      <phone>310-602-5640</phone>
      <email>tstudy1@wgeye.com</email>
    </contact>
    <investigator>
      <last_name>Brittney Rodriguez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ophthalmic Consultants of Connecticut</name>
      <address>
        <city>Fairfield</city>
        <state>Connecticut</state>
        <zip>06824</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denise Lavin</last_name>
      <phone>203-366-8000</phone>
      <email>dlavin@occeye.com</email>
    </contact>
    <investigator>
      <last_name>James Thimons</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Windham Eye Group</name>
      <address>
        <city>Willimantic</city>
        <state>Connecticut</state>
        <zip>06226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Ferro</last_name>
      <phone>860-423-1619</phone>
      <email>weg_heather@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Michael Cooper, OD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Eye Associates of Manatee, LLP</name>
      <address>
        <city>Bradenton</city>
        <state>Florida</state>
        <zip>34209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Stidham</last_name>
      <phone>941-792-2020</phone>
      <phone_ext>2649</phone_ext>
      <email>rstidham@theeyeassociates.com</email>
    </contact>
    <investigator>
      <last_name>Scott Han</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>South Florida Vision</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott Musser</last_name>
      <phone>954-977-0192</phone>
      <email>smusser@2020eyecareplan.com</email>
    </contact>
    <investigator>
      <last_name>Sunir Joshi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bowden Eye &amp; Associates</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32256</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Montgomery</last_name>
      <phone>904-296-0098</phone>
      <email>jmontgomery@bowdeneye.com</email>
    </contact>
    <investigator>
      <last_name>Frank Bowden, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Millenium Clinical Research</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33125</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daylen Diaz</last_name>
      <phone>305-649-7999</phone>
      <email>ddiaz@millenniumresearchfl.com</email>
    </contact>
    <investigator>
      <last_name>orge Alvarez-Moreno</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pediatric &amp; Adult Research Center, LLC</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32825</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shari Tillman</last_name>
      <phone>407-271-4208</phone>
      <email>stillman@parc-clinicaltrials.com</email>
    </contact>
    <investigator>
      <last_name>Maricor Grio</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medsol Clinical Research Center</name>
      <address>
        <city>Port Charlotte</city>
        <state>Florida</state>
        <zip>33948</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <email>mvasconcelos@medsolcrc.com</email>
    </contact>
    <contact_backup>
      <last_name>Maria Vasconcelos</last_name>
      <phone>(941) 623-9744</phone>
      <email>mvasconcelos@medsolcrc.com</email>
    </contact_backup>
    <investigator>
      <last_name>David Klein</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>East Florida Eye Institute</name>
      <address>
        <city>Stuart</city>
        <state>Florida</state>
        <zip>34494</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kacy Brown</last_name>
      <phone>772-287-9000</phone>
      <email>klitchfield@efei.com</email>
    </contact>
    <investigator>
      <last_name>Ronald Frenkel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Logan Ophthalmic Research, LLC</name>
      <address>
        <city>Tamarac</city>
        <state>Florida</state>
        <zip>33321</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine McCall</last_name>
      <phone>954-724-5100</phone>
      <email>cmccall.LOR@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Andrew Logan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>International Research Center</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33603</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernard Perez</last_name>
      <phone>813-875-6588</phone>
      <email>michellew@irctampa.com</email>
    </contact>
    <investigator>
      <last_name>Bernard Perez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saltzer Medical Group</name>
      <address>
        <city>Nampa</city>
        <state>Idaho</state>
        <zip>83686</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Davis</last_name>
      <phone>208-463-3128</phone>
      <email>SSDavis@saltzermed.com</email>
    </contact>
    <investigator>
      <last_name>Ryan McKinnon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wohl Eye Center</name>
      <address>
        <city>Bloomingdale</city>
        <state>Illinois</state>
        <zip>60108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Steger</last_name>
      <phone>630-351-2030</phone>
      <email>michelle@wohleyecenter.com</email>
    </contact>
    <investigator>
      <last_name>Lisa Wohl, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Illinois Eye Center</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61615</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Therese Buie</last_name>
      <phone>309-213-0664</phone>
      <email>tbuie@illinoiseyecenter.com</email>
    </contact>
    <investigator>
      <last_name>Steve Lichtenstein</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MediSphere Medical Research Center, LLC</name>
      <address>
        <city>Evansville</city>
        <state>Indiana</state>
        <zip>47714</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carrisa Covert</last_name>
      <phone>812-471-4110</phone>
      <email>ccovert@medisphereresearch.com</email>
    </contact>
    <investigator>
      <last_name>Alexander Dela LLana</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kannarr Eye Care</name>
      <address>
        <city>Pittsburg</city>
        <state>Kansas</state>
        <zip>66762</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Compton</last_name>
      <phone>620-235-1737</phone>
      <email>mcompton@kannarreyecare.com</email>
    </contact>
    <investigator>
      <last_name>Shane Kannarr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dr. Haider Eye Care</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40220</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Griffith</last_name>
      <phone>502-883-1015</phone>
      <email>acgrif11@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Mohammad Haider</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lakeview Vision</name>
      <address>
        <city>Gretna</city>
        <state>Louisiana</state>
        <zip>70056</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica Monica</last_name>
      <phone>504-391-7560</phone>
      <email>mlong511@bellsouth.net</email>
    </contact>
    <investigator>
      <last_name>Monica Monica</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eye Associates of Northeast Louisiana dba Haik Humble Eye Center</name>
      <address>
        <city>West Monroe</city>
        <state>Louisiana</state>
        <zip>71291</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rebecca Johnson Webb</last_name>
      <phone>318-325-2610</phone>
      <phone_ext>326</phone_ext>
      <email>rajohnson@eyenela.com</email>
    </contact>
    <investigator>
      <last_name>Jonathan Scogin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eye Center Northeast</name>
      <address>
        <city>Bangor</city>
        <state>Maine</state>
        <zip>04401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christie Theriault</last_name>
      <phone>207-990-4388</phone>
      <email>Christie@eyecenternotheast.com</email>
    </contact>
    <investigator>
      <last_name>David Douglas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NECCR PrimaCare Research</name>
      <address>
        <city>Fall River</city>
        <state>Massachusetts</state>
        <zip>02721</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Francoeur</last_name>
      <phone>508-672-7450</phone>
      <phone_ext>21</phone_ext>
      <email>lfrancoeur@neccr.com</email>
    </contact>
    <investigator>
      <last_name>Ehab Sorial</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shire Call Center</name>
      <address>
        <city>Lexington</city>
        <state>Massachusetts</state>
        <zip>02421</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shire Contact</last_name>
      <phone>866-842-5335</phone>
      <email>clinicaltransparency@shire.com</email>
    </contact>
    <investigator>
      <last_name>Shire physician</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Minnesota Eye Consultants, P.A</name>
      <address>
        <city>Bloomington</city>
        <state>Minnesota</state>
        <zip>55431</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Danielle Vitali</last_name>
      <phone>952-567-6070</phone>
      <email>dnvitali@mneye.com</email>
    </contact>
    <investigator>
      <last_name>Ahmad Fahmy</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lifelong Vision Foundation</name>
      <address>
        <city>Chesterfield</city>
        <state>Missouri</state>
        <zip>63017</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lee Stolze</last_name>
      <phone>636-534-5126</phone>
      <email>lstolze@lifelongvisionfoundation.org</email>
    </contact>
    <investigator>
      <last_name>Mujtaba Qazi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NV Eye Physicians</name>
      <address>
        <city>Henderson</city>
        <state>Nevada</state>
        <zip>89074</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kris Taylor</last_name>
      <phone>702-588-1076</phone>
    </contact>
    <investigator>
      <last_name>Lorenz Lorenz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emil A. Stein, M.D., Ltd.</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89129</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emil Stein</last_name>
      <phone>973-937-8839</phone>
      <email>nevadaeyecare@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Emil Stein</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hassman Research Institute</name>
      <address>
        <city>Berlin</city>
        <state>New Jersey</state>
        <zip>08009</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Schwartz</last_name>
      <phone>856-753-7335</phone>
      <email>kschwartz@hritrials.com</email>
    </contact>
    <investigator>
      <last_name>Michael Hassman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northern New Jersey Eye Institute</name>
      <address>
        <city>South Orange</city>
        <state>New Jersey</state>
        <zip>07079</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shirley Vitale</last_name>
      <phone>973-763-2203</phone>
      <email>svitale@nnjei.com</email>
    </contact>
    <investigator>
      <last_name>Charles Crane</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Farkas, Kassalow, Resnick &amp;Associates</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10022</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin Rosin</last_name>
      <phone>212-355-5145</phone>
      <email>eyedockev@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Kevin Rosin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fichte, Endl&amp; Elmer Eyecare</name>
      <address>
        <city>Niagara Falls</city>
        <state>New York</state>
        <zip>14304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen Goodnick</last_name>
      <phone>716-828-8970</phone>
      <email>Kathy.goodnick@fichte.com</email>
    </contact>
    <investigator>
      <last_name>Thomas Elmer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oculus Research at Garner EyeCareCenter</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27603</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol Aune</last_name>
      <phone>713-816-3185</phone>
      <email>carol.aune.oculusresearch@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Carol Aune</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pacific Clear Vision Institute</name>
      <address>
        <city>Eugene</city>
        <state>Oregon</state>
        <zip>97401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Wallace</last_name>
      <phone>541-762-2763</phone>
      <email>jwallace@oregonretina.org</email>
    </contact>
    <investigator>
      <last_name>Bala Ambati</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UPMC Eye Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacki Fisher</last_name>
      <phone>412-383-9033</phone>
      <email>fisherjm2@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>Deepinder Dhaliwal</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wyomissing Optometric Center</name>
      <address>
        <city>Wyomissing</city>
        <state>Pennsylvania</state>
        <zip>19610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Krammes</last_name>
      <phone>610-374-3134</phone>
      <email>hkrammes@wyoopto.com</email>
    </contact>
    <investigator>
      <last_name>Glenn Corbin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bluestein Custom Vision</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29414</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jill Traxler</last_name>
      <phone>843-769-6655</phone>
      <email>bluesteinjill@aol.com</email>
    </contact>
    <investigator>
      <last_name>Ettahleah Bluestein</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eye Specialty Group</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Sanford</last_name>
      <phone>901-685-2200</phone>
      <phone_ext>683</phone_ext>
      <email>michaelsanford@esg.md</email>
    </contact>
    <investigator>
      <last_name>Henry . McQuirter</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nashville Vision Associates</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brandi Wilson</last_name>
      <phone>615-915-5086</phone>
      <email>brandiw@nashvillevision.com</email>
    </contact>
    <investigator>
      <last_name>Gary Jerkins</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Houston Eye Associates</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77025</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carlos Gonzales</last_name>
      <phone>832-280-3642</phone>
    </contact>
    <investigator>
      <last_name>Carlos Gonzales, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DCT- Shah Research, LLC dba Discovery Clinical Trials</name>
      <address>
        <city>Mission</city>
        <state>Texas</state>
        <zip>78572</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Gomez</last_name>
      <phone>956-205-0492</phone>
      <email>mgomez@discoverytrials.com</email>
    </contact>
    <investigator>
      <last_name>Pankajkumar Shah</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lone Star Eye Care, P.A.</name>
      <address>
        <city>Sugar Land</city>
        <state>Texas</state>
        <zip>77479</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Cruz</last_name>
      <phone>832-606-7778</phone>
      <email>toniomd@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Matthew McMenemy</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chrysalis Clinical Research</name>
      <address>
        <city>Saint George</city>
        <state>Utah</state>
        <zip>84790</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rian Farr</last_name>
      <phone>435-656-1704</phone>
      <email>RFarr@sgccr.com</email>
    </contact>
    <investigator>
      <last_name>Jason Hendrix</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emerson Clinical Research Institute</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22046</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olga Zerpa</last_name>
      <phone>202-239-0777</phone>
      <phone_ext>102</phone_ext>
      <email>olga@ecrinstitute.com</email>
    </contact>
    <investigator>
      <last_name>Gustavo Corrales</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chris Smith</last_name>
      <phone>608-263-7169</phone>
      <email>cmsmith37@wisc.edu</email>
    </contact>
    <investigator>
      <last_name>Sarah Nehls</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of the Sunshine Coast Clinical Trials Centre</name>
      <address>
        <city>Sippy Downs</city>
        <state>Queensland</state>
        <zip>4556</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leo Hartley</last_name>
      <phone>(07) 5353 5080</phone>
      <email>leohartley@h2visioncentres.com.au</email>
    </contact>
    <investigator>
      <last_name>Leo Hartley</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Augenklinik, Studienzentrum, Kepler-UniversitÃ¤tsklinikum GmbH</name>
      <address>
        <city>Linz</city>
        <zip>4020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Ring</last_name>
      <phone>+43 05 7680 83 1944</phone>
      <email>michael.ring@kepleruniklinikum.at</email>
    </contact>
    <investigator>
      <last_name>Matthais Bolz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vienna Institute for Research in Ocular Surgery</name>
      <address>
        <city>Vienna</city>
        <zip>1140</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline Pilwachs</last_name>
      <phone>+4319102157564</phone>
      <email>c.pilwachs@viros.at</email>
    </contact>
    <investigator>
      <last_name>Martin KronschlÃ¤ger</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Waterloo</name>
      <address>
        <city>Waterloo</city>
        <state>Ontario</state>
        <zip>N2L 3G1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane Johnson</last_name>
      <phone>(519) 888-4567</phone>
      <phone_ext>35818</phone_ext>
      <email>jane.johnson@uwaterloo.ca</email>
    </contact>
    <investigator>
      <last_name>Lyndon Jones</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinica OftalmolÃ³gica del Caribe S.A.S</name>
      <address>
        <city>Barranquilla</city>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Luis Jose Escaf</last_name>
      <phone>57 5 3363700</phone>
      <phone_ext>139</phone_ext>
    </contact>
    <investigator>
      <last_name>Luis Jose Escaf</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ClÃ­nica de OftalmologÃ­a de Cali S.A</name>
      <address>
        <city>Cali</city>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria del Pilar Echeverri Murgueitio</last_name>
      <phone>57 2 5520890</phone>
      <phone_ext>105</phone_ext>
    </contact>
    <investigator>
      <last_name>Maria del Pilar Echeverri Murgueitio</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de InvestigaciÃ³n en OftalmologÃ­a Ltda.</name>
      <address>
        <city>MedellÃ­n</city>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Claudia Patricia Acosta Cadavid</last_name>
      <phone>57 4 2355888</phone>
    </contact>
    <investigator>
      <last_name>Claudia Patricia Acosta Cadavid</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Eye Clinic Dr Kirsta Turman (Kreutzwaldi Silmakeskus)</name>
      <address>
        <city>Tallinn</city>
        <zip>10120</zip>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rita Utsar</last_name>
      <phone>+372 5152 887</phone>
      <email>ritautsar@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Krista Turman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>East Tallinn Central Hospital Eye Clinic</name>
      <address>
        <city>Tallinn</city>
        <zip>10138</zip>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kadi Palumaa</last_name>
      <phone>+3725200602</phone>
      <email>kadi.palumaa@itk.ee</email>
    </contact>
    <investigator>
      <last_name>Kadi Palumaa</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tartu University Eye Clinic</name>
      <address>
        <city>Tartu</city>
        <zip>51010</zip>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maris Oll</last_name>
      <phone>+3725092657</phone>
      <email>maris.oll@kliinikum.ee</email>
    </contact>
    <investigator>
      <last_name>Maris Oll</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SZTE Szemeszeti Klinika</name>
      <address>
        <city>Szeged</city>
        <state>Csongrad</state>
        <zip>6720</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hadarits Flora</last_name>
      <phone>003630 205 6163</phone>
      <email>hadaritsflora@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Andrea FacskÃ³</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bugat Pal Hospital Clinexpert Gyongyos</name>
      <address>
        <city>Gyongyos</city>
        <state>Heves</state>
        <zip>3200</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabor Erdei</last_name>
      <phone>+36 30 983 0641</phone>
      <email>coordination.clinexpert@bugatpal.hu</email>
    </contact>
    <investigator>
      <last_name>Ilona Elek</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaposi MÃ³r Hospital</name>
      <address>
        <city>KaposvÃ¡r</city>
        <zip>7400</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>BalÃ¡zs Kovacs</last_name>
      <phone>+36 70 312 6040</phone>
      <email>kovacsb.eyemed@gmail.com</email>
    </contact>
    <investigator>
      <last_name>BalÃ¡zs Kovacs</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sharey Zedek MC</name>
      <address>
        <city>Jerusalem</city>
        <zip>9103102</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katz Yael</last_name>
      <phone>+972-2-6666002</phone>
      <email>yaelkatz@szmc.org.il</email>
    </contact>
    <investigator>
      <last_name>David Zadok</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tel Aviv Medicel Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Merav Yehuda</last_name>
      <phone>+972-3-6973912</phone>
      <email>meravy@tlvmc.gov.il</email>
    </contact>
    <investigator>
      <last_name>David Varssano</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne Uno-Med</name>
      <address>
        <city>Krakow</city>
        <state>Malopolska</state>
        <zip>31-070</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michal Wykrota</last_name>
      <phone>605030131</phone>
      <email>michal.wykrota.pl@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Piotr Oleksy</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centrum Diagnostyki i Mikrochirurgii Oka LENS</name>
      <address>
        <city>Olsztyn</city>
        <zip>10-424</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klaudia Kobak</last_name>
      <phone>+48 691463680</phone>
      <email>kobak.lens@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Dominik Zalewski</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne Uno-Med</name>
      <address>
        <city>TarnÃ³w</city>
        <zip>33-100</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Izabella Karska-Basta</last_name>
      <phone>48501533915</phone>
      <email>izabasta@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Izabella Karska-Basta</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Retina Sp. z o.o.</name>
      <address>
        <city>Warszawa</city>
        <zip>01 -364</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ewa Chojnowska</last_name>
      <phone>+ 48 508 582 535</phone>
      <email>e.chojnowska@retina.pl</email>
    </contact>
    <investigator>
      <last_name>Piotr Fryczkowski</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emanuelli Research &amp; Development Center, LLC</name>
      <address>
        <city>Arecibo</city>
        <zip>00613</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diane Perez</last_name>
      <phone>(787) 879-7722</phone>
      <email>dperez.erd@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Andres Emanuelli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro Dotal de Investigaciones de Servicios de Salud</name>
      <address>
        <city>Carolina</city>
        <zip>00984</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daisy Ortiz-Ortiz</last_name>
      <phone>(787) 701-1121</phone>
    </contact>
    <investigator>
      <last_name>Enid Garcia-Rivera</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Berrocal and Associates</name>
      <address>
        <city>San Juan</city>
        <zip>00907</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Berrocal</last_name>
      <phone>787-725-9315</phone>
      <email>mariahberrocal@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Maria Berrocal</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Newtown Clinical Research Centre</name>
      <address>
        <city>Johannesburg</city>
        <state>Gauteng</state>
        <zip>2001</zip>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Busie Zwane</last_name>
      <phone>+27114920336</phone>
      <email>busie@newtowncrc.co.za</email>
    </contact>
    <investigator>
      <last_name>Essack Mitha</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pretoria Eye Institute</name>
      <address>
        <city>Pretoria</city>
        <state>Gauteng</state>
        <zip>0082</zip>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janet van Oordt</last_name>
      <phone>+2712 343 2425</phone>
      <email>janetvo@eyeinstitute.co.za</email>
    </contact>
    <investigator>
      <last_name>Petrus Nicolaas Jacobus Gous</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Into Research</name>
      <address>
        <city>Pretoria</city>
        <state>Gauteng</state>
        <zip>0181</zip>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria E Booysen</last_name>
      <phone>+27 12 460 1160</phone>
      <email>booysenmaria@ymail.com</email>
    </contact>
    <investigator>
      <last_name>Heidi Siebert</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instituto OftalmolÃ³gico FernÃ¡ndez-Vega</name>
      <address>
        <city>Oviedo</city>
        <state>Asturias</state>
        <zip>33012</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>SILVIA BERISA</last_name>
      <phone>+34985240141</phone>
      <email>silvia.berisa@fernandez-vega.com</email>
    </contact>
    <investigator>
      <last_name>JesÃºs Merayo-Lloves</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinica Oftalmologia Gil PiÃ±a</name>
      <address>
        <city>Huelva</city>
        <zip>21002</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maribel Perez Marquez</last_name>
      <phone>+34959261544</phone>
      <email>administracion@gilpiÃ±a.com</email>
    </contact>
    <investigator>
      <last_name>Gil Pina</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinica Rementeria</name>
      <address>
        <city>Madrid</city>
        <zip>28010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>INES CONTRERAS</last_name>
      <phone>0034 913083838</phone>
      <email>contreras@clinicarementeria.es</email>
    </contact>
    <investigator>
      <last_name>Francisco Javier Hurtado CeÃ±a</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cartujavision</name>
      <address>
        <city>Sevilla</city>
        <zip>41092</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JesÃºs Montero</last_name>
      <phone>(34) 954223066</phone>
    </contact>
    <investigator>
      <last_name>JesÃºs Montero</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Austria</country>
    <country>Canada</country>
    <country>Colombia</country>
    <country>Estonia</country>
    <country>Hungary</country>
    <country>Israel</country>
    <country>Poland</country>
    <country>Puerto Rico</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 19, 2016</study_first_submitted>
  <study_first_submitted_qc>December 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2016</study_first_posted>
  <last_update_submitted>January 19, 2018</last_update_submitted>
  <last_update_submitted_qc>January 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Conjunctivitis</mesh_term>
    <mesh_term>Conjunctivitis, Bacterial</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
    <mesh_term>Ophthalmic Solutions</mesh_term>
    <mesh_term>Iodine</mesh_term>
    <mesh_term>Povidone-Iodine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

